Cardinal Health Recalls Epinephrine Auto-Injectors Due to Temperature Excursions
Cardinal Health is recalling 1,776 boxes of Epinephrine auto-injectors due to intermittent exposure to temperature excursions during storage.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard is a CGMP deviation (temperature excursion) without reported illnesses or injuries, fitting the criteria for a moderate severity voluntary precautionary recall.
Plain-English summary
Cardinal Health Inc. is recalling 1,776 boxes of Epinephrine Injection USP, 0.15 mg (Auto-Injectors) for Allergic Emergencies (Anaphylaxis). The product, manufactured for Teva Pharmaceuticals USA, Inc., is identified by NDC 0093-5985-27 and lot code 025C20AA. The recall is being conducted due to CGMP deviations involving intermittent exposure to temperature excursions during storage.
The affected product was distributed in Florida, Georgia, and South Carolina. The recall is classified as Class II by the FDA, indicating a situation where use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Consumers who have this product should stop using it and contact their healthcare provider or pharmacist for further instructions. The recall is limited to the specific lot and distribution areas mentioned.
The recalled product
- Product
- EPINEPHRINE (EPINEPHRINE)
- Brand
- EPINEPHRINE
- Manufacturer
- Cardinal Health Inc.
- Category
- Drug — Prescription Drug
- Affected units
- 1,776
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- 025C20AA
UPCs (2)
- 0300935985275
- 0300935986272
Distribution
Part of a larger recall action
This product is one of 198 recalled by Cardinal Health Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 198 products in this recall →Related recalls
Same brand · EPINEPHRINE
- CriticalAmerican Regent Recalls Epinephrine Vials Due to Particulate Matter
FDA (Drugs) · 2026-09-16
- ModerateFresenius Kabi epinephrine injection vials failed impurities and degradation specifications
FDA (Drugs) · 2026-06-17
- HighIMS epinephrine injection vials recalled over lack of sterility assurance
FDA (Drugs) · 2026-04-22
- HighEpinephrine Auto-Injector Recalled for Temperature Abuse During Manufacturing and Distribution
FDA (Drugs) · 2022-06-15
- HighFDA Recalls Epinephrine Auto-Injectors Due to Temperature Abuse
FDA (Drugs) · 2022-06-15
Same manufacturer · Cardinal Health Inc.
See all →- HighEnoxaparin syringe bags recalled after being labeled with the wrong strength
FDA (Drugs) · 2025-09-03
- ModerateXolair auto-injectors exposed to temperatures outside labeled storage requirements
FDA (Drugs) · 2025-08-13
- ModerateRecombinate antihemophilic factor vials exposed to temperatures outside labeled storage
FDA (Drugs) · 2025-08-13
- ModerateXolair 75 mg syringes exposed to temperatures outside labeled storage requirements
FDA (Drugs) · 2025-08-13
- ModerateWegovy injection recalled due to temperature exposure during shipping
FDA (Drugs) · 2025-05-07
Same hazard · temperature excursion
See all →- ModerateCyclophosphamide injection vials recalled after a transportation temperature excursion
FDA (Drugs) · 2025-09-24
- ModerateProlia prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateBenlysta vials recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateEvenity prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
Similar recalls
- ModerateTeva Recalls Epinephrine Auto-Injectors Due to CGMP Deviations
FDA (Drugs) · 2020-05-13
- HighEpinephrine Auto-Injector Recalled for Temperature Abuse During Manufacturing and Distribution
FDA (Drugs) · 2022-06-15
- HighFDA Recalls Epinephrine Auto-Injectors Due to Temperature Abuse
FDA (Drugs) · 2022-06-15
- HighPrescription EpiPen auto-injectors recalled for temperature-abuse manufacturing defect
FDA (Drugs) · 2022-06-15
- HighEpiPen epinephrine auto-injectors recalled for manufacturing temperature deviation
FDA (Drugs) · 2022-06-15
- HighAdrenalin epinephrine vials recalled nationwide due to temperature-abuse deviations
FDA (Drugs) · 2022-06-15